Watson’s Mesalazine API Production Pursuing DMF Registration in the EU and Japan
Mesalazine, also known as mesalamine, is a highly effective anti-inflammatory drug widely used in the treatment of inflammatory bowel diseases (IBD), particularly ulcerative colitis. Derived from 5-aminosalicylic acid (5-ASA), mesalazine boasts a well-established therapeutic profile, offering targeted relief and long-term benefits for patients. Applications of Mesalazine Mesalazine serves as the active component of sulfasalazine (SASP),
